Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Employee Benefits Procurement topic
No spam. Unsubscribe anytime.
Johnson County approves new group medical and pharmacy contracts after public comment on cost weighting
Summary
Johnson County commissioners approved contracts with Blue KC for medical administration and with Med 1 and Tria Health for pharmacy and medication-therapy services after staff described projected clinical savings; public commenters questioned the evaluation's low relative weighting for cost.
Johnson County commissioners authorized new contracts for employee health benefits, approving a group medical administration contract with Blue Cross Blue Shield of Kansas City (Blue KC) and pharmacy and medication-therapy contracts with Med 1 Pharmacy Benefit Solutions and Tria Health LLC.
Cameron Ahrens, the county benefits presenter, told commissioners the evaluation team included representatives from the sheriff's office, budget, human resources and financial management. Blue KC was recommended for medical administration in part because the vendor provided a discount guarantee and a large, local provider network with a "total care" primary-care network the county believes helps control chronic-condition costs. Ahrens said Blue KC provided a discount guarantee of 65 percent and that the county estimated additional savings of $1.4 million per year due to better chronic-condition management. The board approved the medical administration contract with an estimated annual administrative cost not to exceed $2,000,000, subject to the FY2026 budget, and authorized plan design changes and employee contribution adjustments for the 2026 plan year.
On pharmacy services, commissioners heard public comment critical of the evaluation rubric's weight on subjective criteria and low weight on cost. A public commenter argued the county's scoring treated cost as a tertiary consideration and that the bids varied widely. Ahrens and commissioners responded that the evaluation considered ingredient cost, dispensing fees, and guarantees of clinical savings. He said Med 1 included a $3.1 million clinical guarantee and programs to increase use of biosimilars and clinical pharmacist interventions, which the evaluation team concluded would produce greater net savings than choosing the low administrative-cost bidder. Commissioners approved a pharmacy administration contract with Med 1 not to exceed $300,000 annually and a medication therapy management contract with Tria Health LLC not to exceed $600,000 annually, effective Jan. 1, 2026, with options to renew; approvals were subject to the FY2026 budget.
The votes were conducted by roll call. The Blue KC medical administration contract passed 7-0. The combined Med 1/Tria Health motion passed 7-0 after commissioners discussed differences in proposals and the value of guaranteed clinical savings.
Several commissioners voiced support for balancing fiscal restraint with retaining and recruiting county employees, citing the county's intent to maintain a competitive benefits package. Ahrens said negotiation items include claim-handling personnel and value-added services that some vendors bundle or charge extra for; county staff said those services were part of the evaluation.
The public record includes comments urging greater transparency about total compensation and a higher weighting for cost in procurement evaluations; county staff responded that the evaluation included projected net cost consequences, not only administrative fees.
